CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.3489
-0.0177 (-4.83%)
At close: Jun 30, 2026, 4:00 PM EDT
0.3430
-0.0059 (-1.69%)
After-hours: Jun 30, 2026, 7:54 PM EDT
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $5.03 million as of June 30, 2026. Its market cap has decreased by -69.13% in one year.
Market Cap
5.03M
Enterprise Value
3.33M
1-Year Change
-69.13%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has decreased from $30.60M to $5.03M, a decrease of -83.55%. That is a compound annual growth rate of -19.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 5.03M | -71.89% |
| Dec 31, 2025 | 17.90M | -56.55% |
| Dec 31, 2024 | 41.20M | -43.72% |
| Dec 29, 2023 | 73.20M | -20.95% |
| Dec 30, 2022 | 92.60M | -47.06% |
| Dec 31, 2021 | 174.90M | 147.03% |
| Dec 31, 2020 | 70.80M | 226.27% |
| Dec 31, 2019 | 21.70M | 55.00% |
| Dec 31, 2018 | 14.00M | -54.25% |
| Jan 31, 2018 | 30.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 5.68M |
| PMGC Holdings | 5.63M |
| Decoy Therapeutics | 5.54M |
| Processa Pharmaceuticals | 5.50M |
| Alaunos Therapeutics | 5.45M |
| Adial Pharmaceuticals | 5.31M |
| Dermata Therapeutics | 5.27M |
| Genprex | 5.21M |